South Korea · Delayed Price · Currency is KRW JW Pharmaceutical Statistics
Total Valuation
KRX:001060 has a market cap or net worth of KRW 643.59 billion. The enterprise value is 613.26 billion.
| Market Cap | 643.59B |
| Enterprise Value | 613.26B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KRX:001060 has 22.89 million shares outstanding. The number of shares has decreased by -10.27% in one year.
| Current Share Class | 22.55M |
| Shares Outstanding | 22.89M |
| Shares Change (YoY) | -10.27% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 8.48% |
| Float | 12.90M |
Valuation Ratios
The trailing PE ratio is 6.33.
| PE Ratio | 6.33 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 1.57 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | 5.24 |
| P/OCF Ratio | 4.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.73, with an EV/FCF ratio of 4.99.
| EV / Earnings | 6.11 |
| EV / Sales | 0.75 |
| EV / EBITDA | 4.73 |
| EV / EBIT | 5.57 |
| EV / FCF | 4.99 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.56 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.56 |
| Debt / FCF | 0.58 |
| Interest Coverage | 24.37 |
Financial Efficiency
Return on equity (ROE) is 27.63% and return on invested capital (ROIC) is 25.28%.
| Return on Equity (ROE) | 27.63% |
| Return on Assets (ROA) | 10.78% |
| Return on Invested Capital (ROIC) | 25.28% |
| Return on Capital Employed (ROCE) | 24.55% |
| Weighted Average Cost of Capital (WACC) | 9.29% |
| Revenue Per Employee | 769.32M |
| Profits Per Employee | 94.11M |
| Employee Count | 1,068 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 3.74 |
Taxes
In the past 12 months, KRX:001060 has paid 14.02 billion in taxes.
| Income Tax | 14.02B |
| Effective Tax Rate | 12.16% |
Stock Price Statistics
The stock price has increased by +26.85% in the last 52 weeks. The beta is 0.99, so KRX:001060's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +26.85% |
| 50-Day Moving Average | 25,354.00 |
| 200-Day Moving Average | 28,299.25 |
| Relative Strength Index (RSI) | 55.54 |
| Average Volume (20 Days) | 77,188 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:001060 had revenue of KRW 820.86 billion and earned 100.42 billion in profits. Earnings per share was 4,453.47.
| Revenue | 820.86B |
| Gross Profit | 388.22B |
| Operating Income | 107.82B |
| Pretax Income | 115.30B |
| Net Income | 100.42B |
| EBITDA | 127.31B |
| EBIT | 107.82B |
| Earnings Per Share (EPS) | 4,453.47 |
Balance Sheet
The company has 102.08 billion in cash and 71.75 billion in debt, with a net cash position of 30.33 billion or 1,325.38 per share.
| Cash & Cash Equivalents | 102.08B |
| Total Debt | 71.75B |
| Net Cash | 30.33B |
| Net Cash Per Share | 1,325.38 |
| Equity (Book Value) | 409.94B |
| Book Value Per Share | 17,911.34 |
| Working Capital | 123.86B |
Cash Flow
In the last 12 months, operating cash flow was 134.48 billion and capital expenditures -11.67 billion, giving a free cash flow of 122.81 billion.
| Operating Cash Flow | 134.48B |
| Capital Expenditures | -11.67B |
| Depreciation & Amortization | 19.49B |
| Net Borrowing | -20.84B |
| Free Cash Flow | 122.81B |
| FCF Per Share | 5,365.77 |
Margins
Gross margin is 47.29%, with operating and profit margins of 13.13% and 12.34%.
| Gross Margin | 47.29% |
| Operating Margin | 13.13% |
| Pretax Margin | 14.05% |
| Profit Margin | 12.34% |
| EBITDA Margin | 15.51% |
| EBIT Margin | 13.13% |
| FCF Margin | 14.96% |
Dividends & Yields
This stock pays an annual dividend of 650.00, which amounts to a dividend yield of 2.37%.
| Dividend Per Share | 650.00 |
| Dividend Yield | 2.37% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 9 |
| Payout Ratio | 15.51% |
| Buyback Yield | 10.27% |
| Shareholder Yield | 12.64% |
| Earnings Yield | 15.60% |
| FCF Yield | 19.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:001060 has an Altman Z-Score of 4.02 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.02 |
| Piotroski F-Score | 7 |